New hires, expanded manufacturing capacity fuel the success of today's #1 alternative to ibuprofen and NSAIDs™
MADISON, Tenn., Oct. 24, 2012 /PRNewswire/ — Millions of consumers seek pain relief daily. Not everyone, however, reaches for prescribed medications or popular over-the-counter (OTC) drugs, which can have dangerous side effects and addictive properties. More and more, consumers are looking to the nutraceutical industry for alternative options, such as AminoActiv®, developed and made by Vireo Systems, Inc., a Tennessee-based company that recently expanded its manufacturing capacity in Nebraska and won a $20,000 job training grant from the Nebraska Department of Economic Development. This grant will help the company hire and train more production technicians to keep up with demand.
Vireo's newly expanded facility, located in Plattsmouth, Neb., houses Vireo Resources, a subsidiary of the Madison, Tenn.-based Vireo Systems. Thanks to the grant, new hires are expanding the Vireo team to meet the demand for AminoActiv — one of the company's flagship products and the #1 alternative to ibuprofen and non-steroidal, anti-inflammatory drugs known as NSAIDs. Available in capsules and as a topical cream, AminoActiv stabilizes the body's natural resistance to cellular events that produce inflammation and related pain. Users of AminoActiv report relief from pain associated with a wide range of maladies, including arthritis, muscle strain, joint and back injury, fibromyalgia, plantar fasciitis, headaches and menstrual cramps.
"The grant could not have been better timed for Vireo as we continue our trajectory of growth," stated Mark Faulkner, president of Vireo. "We are grateful for this opportunity to create jobs and augment the Vireo team's mission to provide proven anti-inflammatory and pain relief solutions."
A key component of that mission is delivering solutions that are not only effective but also safe, natural and nontoxic. As reported in clinical trials, NSAIDs can have serious side effects, including stomach bleeding and kidney toxicity. They can also impede protein synthesis, repair of tendons and ligaments, and bone recalcification.
"Certain prescribed and popular OTC drugs can carry serious risks for patients," Faulkner explained. "Meanwhile, safety studies performed at a major university medical center have demonstrated that AminoActiv has no harmful side effects, and millions of doses have been taken with no reported side effects. Patients tell us that AminoActiv is a godsend because it relieves both chronic and acute pain. AminoActiv achieves this not by masking pain but by promoting patient health and tissue recovery."
For more information, visit http://aminoactiv.com.
About Vireo Systems, Inc.
Taking inspiration from one of the Latin words for "health," Vireo Systems, Inc. is the manufacturer of a number of health-related products including AminoActiv, the #1 leading alternative to ibuprofen and NSAIDs. Vireo was founded in 2002 as part of a project with several university-based researchers, and today, the company's products deliver safe, effective relief for inflammation and pain. Vireo meets industry-standard good manufacturing practices as expected by the FDA, and AminoActiv safety and toxicity data have been reviewed and accepted by the FDA.
Vireo is headquartered just outside Nashville, Tenn., with a secondary facility in Plattsmouth, Neb., where it manufactures its pain relief capsules and cream. Vireo is a two-time nominee for the NEXT Award, a prestigious honor celebrating successful businesses in the Middle Tennessee Region and part of an annual recognition program sponsored by the Nashville Area Chamber of Commerce and Entrepreneurial Center.
President, Vireo Systems, Inc.